摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-Dimethoxybenzaldehyde ethylene acetal | 140464-70-6

中文名称
——
中文别名
——
英文名称
3,5-Dimethoxybenzaldehyde ethylene acetal
英文别名
3,5-dimethoxy-1-(1,3-dioxolan-2-yl)benzene;2-(3,5-dimethoxyphenyl)-[1,3]dioxolan;2-(3,5-Dimethoxyphenyl)-1,3-dioxolane
3,5-Dimethoxybenzaldehyde ethylene acetal化学式
CAS
140464-70-6
化学式
C11H14O4
mdl
——
分子量
210.23
InChiKey
JQNWRIDXOJJUIG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    321.2±42.0 °C(Predicted)
  • 密度:
    1.148±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    36.9
  • 氢给体数:
    0
  • 氢受体数:
    4

SDS

SDS:e6bda2c2da7da67f978b2f5d0fc1474a
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,5-Dimethoxybenzaldehyde ethylene acetal 在 molybdenum(VI) oxide on silica 作用下, 以 丙酮 为溶剂, 反应 0.88h, 生成 3,5-二甲氧基苯甲醛
    参考文献:
    名称:
    Protection and Deprotection of Acetals by Using MoO3/SiO2
    摘要:
    Acetalization of aldehydes using a new silica-supported molybdenum(VI) oxide (20%) catalyst has been explored. Additionally, facile deprotection strategy for the acetals is reported including the results from the replacement of solvent studies. The protocol achieved the protection O,O-acetals in excellent yield within a few hours under neutral conditions and also deprotection of aromatic O,O-acetals in excellent yields was achieved within a few minutes in aqueous acetone.
    DOI:
    10.1080/15459620500408868
  • 作为产物:
    描述:
    3,5-二甲氧基苯甲醛乙二醇 在 camphor-10-sulfonic acid 作用下, 以 为溶剂, 反应 16.0h, 以95%的产率得到3,5-Dimethoxybenzaldehyde ethylene acetal
    参考文献:
    名称:
    完全保护的对映肌idi酸的不对称合成。
    摘要:
    [结构:见正文]描述了一种完全保护的对-肌ino二酸衍生物14的不对称合成。作为关键步骤,应用了芳烃三羰基铬(0)络合物的对映选择性去质子化和非对映选择性Suzuki偶联。氨基酸功能的不对称中心是通过立体控制的Strecker反应产生的。
    DOI:
    10.1021/ol016218n
点击查看最新优质反应信息

文献信息

  • Asymmetric Synthesis of a Fully Protected <i>e</i><i>nt</i>-Actinoidinic Acid
    作者:René Wilhelm、David A. Widdowson
    DOI:10.1021/ol016218n
    日期:2001.10.1
    [structure: see text] The asymmetric synthesis of a fully protected ent-actinoidinic acid derivative 14 is described. As key steps, an enantioselective deprotonation of an arene tricarbonylchromium(0) complex and a diastereoselective Suzuki coupling were applied. The asymmetric centers of the amino acid function were created via stereocontrolled Strecker reactions.
    [结构:见正文]描述了一种完全保护的对-肌ino二酸衍生物14的不对称合成。作为关键步骤,应用了芳烃三羰基铬(0)络合物的对映选择性去质子化和非对映选择性Suzuki偶联。氨基酸功能的不对称中心是通过立体控制的Strecker反应产生的。
  • 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
    申请人:Schwede Wolfgang
    公开号:US20090030010A1
    公开(公告)日:2009-01-29
    This invention relates to compounds of general formula I in which R 1 and R 2 are described in this application, the use of the compounds of general formula I as inhibitors of protein tyrosine kinases for treatment of various diseases as well as the compounds of general formulas II and III as intermediate compounds for the production of compounds of general formula I, whereby X, R 1a and R 2a have the meaning that is described in general formulas II and III.
    本发明涉及一般式I的化合物,其中R1和R2在本申请中被描述,一般式I的化合物用作蛋白质酪氨酸激酶的抑制剂以治疗各种疾病,以及一般式II和III的化合物作为一般式I的化合物的中间体化合物的使用,其中X,R1a和R2a具有在一般式II和III中描述的含义。
  • 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
    申请人:Bayer Schering Pharma AG
    公开号:US07977325B2
    公开(公告)日:2011-07-12
    This invention relates to compounds of general formula I in which R1 and R2 are described in this application, the use of the compounds of general formula I as inhibitors of protein tyrosine kinases for treatment of various diseases as well as the compounds of general formulas II and III as intermediate compounds for the production of compounds of general formula I, wherein X, R1a and R2a have the meaning that is described in general formulas II and III.
    本发明涉及通式I的化合物,其中R1和R2在本申请中有所描述,通式I的化合物作为蛋白酪氨酸激酶的抑制剂用于治疗各种疾病,以及通式II和III的化合物作为通式I化合物的中间体化合物的生产,其中X、R1a和R2a具有通式II和III中所描述的含义。
  • WO2006/63805
    申请人:——
    公开号:——
    公开(公告)日:——
  • Regioselective reductive electrophilic substitution of derivatives of 3,4,5-trimethoxybenzaldehyde
    作者:Ugo Azzena、Giovanni Melloni、Anna Maria Piroddi、Emanuela Azara、Stefania Contini、Emma Fenude
    DOI:10.1021/jo00037a029
    日期:1992.5
    The behavior of several protected derivatives of 3,4,5-trimethoxybenzaldehyde has been investigated under conditions of electron transfer from alkali metals in aprotic solvents. The 4-methoxy group can be regioselectively removed in good to high yield under such conditions, and an appropriate choice of the protecting group, metal, and solvent allows its substitution with a variety of electrophiles. 3,4,5-Trimethoxybenzaldehyde dimethyl acetal, 1, is the starting material of choice for a new general synthetic approach to several polysubstituted resorcinol dimethyl ethers. Investigation of the mechanism of demethoxylation, with the aid of labeling experiments, showed that reductive demethoxylation is strongly influenced by the nature of the aldehyde protective group employed.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐